Paper37239140
COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence.
Hromić-Jahjefendić A and 8 others. Biomedicines, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence. Papers, record 37239140. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37239140
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References113
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32441789 | Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. | J Med Virol | 2020 | https://conductscience.org/library/papers/32441789 | PubMed |
| 2 | 34246566 | COVID-19 vaccines and myocarditis. | Arch Cardiovasc Dis | 2021 | https://conductscience.org/library/papers/34246566 | PubMed |
| 3 | 35813276 | Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series. | Lancet Healthy Longev | 2022 | https://conductscience.org/library/papers/35813276 | PubMed |
| 4 | 35667917 | Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study. | Vaccine | 2022 | https://conductscience.org/library/papers/35667917 | PubMed |
| 5 | 33956782 | Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021. | MMWR Morb Mortal Wkly Rep | 2021 | https://conductscience.org/library/papers/33956782 | PubMed |
| 6 | 36266115 | A Systematic Review and Meta-analysis of the Association Between SARS-CoV-2 Vaccination and Myocarditis or Pericarditis. | Am J Prev Med | 2023 | https://conductscience.org/library/papers/36266115 | PubMed |
| 7 | 35950151 | Constrictive pericarditis following inactivated virus COVID-19 vaccine: a case report with review of the literature. | Radiol Case Rep | 2022 | https://conductscience.org/library/papers/35950151 | PubMed |
| 8 | 3455232 | Myocarditis. A histopathologic definition and classification. | Am J Cardiovasc Pathol | 1987 | https://conductscience.org/library/papers/3455232 | PubMed |
| 9 | 36441403 | COVID-19 Vaccine-Related Myocardial and Pericardial Inflammation. | Curr Cardiol Rep | 2022 | https://conductscience.org/library/papers/36441403 | PubMed |
| 10 | 35993236 | Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex. | Circulation | 2022 | https://conductscience.org/library/papers/35993236 | PubMed |
| 11 | 34043894 | Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34043894 | PubMed |
| 12 | 34907393 | Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. | Nat Med | 2022 | https://conductscience.org/library/papers/34907393 | PubMed |
| 13 | 35233481 | Effusive-constrictive pericarditis after the second dose of BNT162b2 vaccine (Comirnaty): a case report. | Eur Heart J Case Rep | 2022 | https://conductscience.org/library/papers/35233481 | PubMed |
| 14 | 26063472 | Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Lancet | 2015 | https://conductscience.org/library/papers/26063472 | PubMed |
| 15 | 35967168 | Covaxin-Induced Lymphocytic Myocarditis. | Cureus | 2022 | https://conductscience.org/library/papers/35967168 | PubMed |
| 16 | 32227090 | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. | Cardiovasc Res | 2020 | https://conductscience.org/library/papers/32227090 | PubMed |
| 17 | 32965010 | SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications? | Eur Rev Med Pharmacol Sci | 2020 | https://conductscience.org/library/papers/32965010 | PubMed |
| 18 | 34952008 | mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. | J Pediatr | 2022 | https://conductscience.org/library/papers/34952008 | PubMed |
| 19 | 35076665 | Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. | JAMA | 2022 | https://conductscience.org/library/papers/35076665 | PubMed |
| 20 | 35333945 | Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study. | Clin Res Cardiol | 2022 | https://conductscience.org/library/papers/35333945 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974066 | Adverse effects of FDA-approved RNA therapeutics: a cross-platform analysis of RNA design, delivery systems, and safety profiles. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42974066 | PubMed |
| 39858903 | COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis. | Microorganisms | 2025 | https://conductscience.org/library/papers/39858903 | PubMed |
| 39693192 | Scrutinizing the COVID-19 vaccine safety debate. | Hum Vaccin Immunother | 2024 | https://conductscience.org/library/papers/39693192 | PubMed |
| 38988090 | Comparative safety of monovalent and bivalent mRNA COVID-19 booster vaccines in adolescents aged 12 to 17 years in the Republic of Korea. | Osong Public Health Res Perspect | 2024 | https://conductscience.org/library/papers/38988090 | PubMed |
| 37799242 | COVID-19-Associated Acute Myocarditis: Risk Factors, Clinical Outcomes, and Implications for Early Detection and Management. | Cureus | 2023 | https://conductscience.org/library/papers/37799242 | PubMed |
| 37732113 | Myocarditis Following Inactivated SARS-CoV-2 Vaccine (Vero Cell) in an Adult Female in Vietnam: A Case Report. | Int Med Case Rep J | 2023 | https://conductscience.org/library/papers/37732113 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| CXADR | 1525 | PubTator's text mining | https://conductscience.org/library/genes/1525 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| VTN | 7448 | PubTator's text mining | https://conductscience.org/library/genes/7448 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37239140
GET https://conductscience.org/api/papers/v1/37239140/references?page=2